Lyra Therapeutics Reports Positive Topline Results From BEAC

Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery.

Related Keywords

California , United States , Sheng Kee , Morgan Stanley , Retailer Kohl Corp , Drug Administration , California Inc , Tesla Inc , Retailer Kohl , Magic Mixies Genie Lamp , Magic Whispers Lune , Little Live Pets My Puppy , Disney Princess Royal Adventures Castle , Treasure Chest , Mooncake Gift Boxes , Assorted Mooncake Gift Box , Assorted Mooncake Tin Gift Box , Lyra Therapeutics , Kyra , Iotechnology Company Lyra , Eacon Phase 2 Clinical Study , Lyr 220 , Thmoid Sinus Surgery ,